🇺🇸 FDA
Patent

US 7420100

Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression

granted A61PA61P9/00A61P9/10

Quick answer

US patent 7420100 (Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression) held by The Board of Regents of the University of Texas System expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P9/00, A61P9/10